Search for: "In re: Apple, Inc." Results 1101 - 1120 of 1,245
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
9 May 2008, 10:30 pm
You can separately subscribe to the IP Thinktank Global week in Review at the Subscribe page: [duncanbucknell.com] Highlights this week included: Order to transfer myspace.co.uk to MySpace overturned: (Out-Law), (IMPACT), New branding scheme for Ethiopian coffees: (Afro-IP), (IP finance), (IPKat), USPTO to appeal Tafas/GSK v Dudas: (Patent Docs), (Patently-O), (PLI), (Patent Baristas), (Managing Intellectual Property), (IP Law360), (Patent Prospector), (Ladas & Parry), … [read post]
24 Sep 2020, 4:01 am by Greg Lambert
Listen, Subscribe, Comment Please take the time to rate and review us on Apple Podcast. [read post]
31 Aug 2022, 10:21 pm by Bennett Cyphers
Users who do not install many third-party apps, or who have opted out of tracking via Apple’s App Tracking Transparency (ATT), may not be present in the dataset at all. [read post]
5 Dec 2019, 10:43 am by Rebecca Tushnet
If Burstein is right [she is], then they’re no longer applying utility patent standard, which is what they wanted from design right. [read post]
19 May 2009, 2:51 am
According to IBM, that is more than the number of patents of six major competitors -- Hewlett-Packard Co., Apple Inc., EMC Corp., Microsoft Corp., Google Inc., and Oracle Corp. -- combined.What else are they doing right when not leading the charge in patent applications? [read post]
27 Jun 2008, 10:04 am
Here is IP Think Tank’s weekly selection of top intellectual property news breaking in the blogosphere and internet. [read post]
10 May 2019, 9:12 am by Eric Goldman
Strauss’ hashtags may fall short on the second or third factor, but it’s hard to reconcile with prior case law the assertion that they’re not being used to reference Align’s goods but instead solely to describe Strauss’s. [read post]
23 Jun 2020, 11:30 am by David Jensen
  Just this spring, Gilead Sciences, Inc., of Foster City, Ca., bought a firm backed directly and indirectly by CIRM with $45 million. [read post]
2 Feb 2015, 2:20 am
Last week was another busy one at the IPKat, so it may not be surprising if some missed a post or two. [read post]
16 Feb 2015, 1:44 am
 Here comes the 33rd weekly round-up of last week's Katposts, recorded by the sensitive pen of Katfriend par excellence Alberto Bellan, who writes as follows:* When friendship is re-interpreted: Italy and San Marino take new view on IP rights Italy and San Marino's treaty on IP recognition seems to be over. [read post]
4 Jul 2013, 5:00 am by Bexis
Cornerstone Therapeutics, Inc., 2013 WL 3198153 (2d Cir. [read post]
10 Dec 2016, 5:02 am by Florian Mueller
It's a communication about the referred site.Nor does such a link constitute a "making available [...] of" whatever may be on the other site (unless, which is not what we're talking about here, the other site is password-protected and you need to go through some other site to gain access). [read post]
18 Apr 2008, 2:00 am
Lélos Kai Sia EE (and Others) v GlaxoSmithKline AEVE: (IPKat), US: Bio commends Sen Specter for patent reform stance: (Patent Docs), US: USPTO rules on two of four neural stem cell patents in dispute between StemCells Inc and Neuralstem Inc; parties disagree on how extensively claims amended: (IP Law360), (IPBiz), US: Insmed continues fight for generic biologic approval: (GenericsWeb), Pharma & Biotech - Products Cipralex (Escitalopram)… [read post]
14 Feb 2009, 11:56 am
This post is by my colleagues Gail Lees, Andrew Tulumello, Chip Nierlich, Mark Whitburn and Chris Chorba. [read post]